Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Defendant: Teva Pharmaceuticals USA, Inc.
Case Number: 1:2019cv02202
Filed: November 26, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 1
Jury Demanded By: None
Docket Report

This docket was last retrieved on January 23, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 23, 2020 Pro Hac Vice Attorney Jennifer Rea Deneault, Nicholas Groombridge, Daniel J. Klein, and Josephine Young for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC(mal)
January 14, 2020 Opinion or Order Filing 12 ORDER: On or before February 14, 2020, counsel for plaintiff shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: Notice of Compliance deadline set for 2/14/2020. Signed by Judge Colm F. Connolly on 1/14/2020. Associated Cases: 1:19-cv-02202-CFC, 1:19-cv-02375-CFC(nmf)
January 7, 2020 Opinion or Order SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/7/2020. (fms)
January 6, 2020 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek)
January 6, 2020 Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
January 6, 2020 Filing 9 ANSWER to #1 Complaint , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
December 31, 2019 Filing 8 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487 AMENDED. (Fahnestock, Derek)
December 5, 2019 Filing 7 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to January 8, 2020 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen)
December 5, 2019 Filing 6 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 12/4/2019, answer due 12/26/2019. (Fahnestock, Derek)
December 5, 2019 Opinion or Order SO ORDERED, re #7 STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to January 8, 2020 filed by Teva Pharmaceuticals USA, Inc. Set/Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 1/8/2020. Signed by Judge Colm F. Connolly on 12/5/2019. (fms)
December 4, 2019 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
November 26, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (mal)
November 26, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,376,487. (mal)
November 26, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/16/2019. Date of Expiration of Patent: 07/27/2035.Thirty Month Stay Deadline: 7/31/2021. (mal)
November 26, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
November 26, 2019 Filing 1 COMPLAINT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2788585.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal)
November 26, 2019 Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 11/26/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mal)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Represented By: Karen Elizabeth Keller
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Vanda Pharmaceuticals Inc.
Represented By: Derek James Fahnestock
Represented By: Karen Jacobs
Represented By: Jennifer Rea Deneault
Represented By: Josephine Young
Represented By: Daniel J. Klein
Represented By: Nicholas Groombridge
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?